UPBD vs VRTX · P/E 12, rev $4.32B vs P/E 30, rev $12.00B
Upbound Group Inc. (UPBD) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Upbound Group Inc. (UPBD) is a software - application company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported UPBD revenue for 2024-12-31 was $4.32B. Net income was $123.5M. Revenue was up 8.2% from 2023-12-31 to 2024-12-31. UPBD currently screens at market cap $1.02B and trailing P/E 12.1.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
UPBD currently screens at market cap $1.02B and trailing P/E 12.1. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the UPBD and VRTX stock pages for the full models.
Not investment advice.